Ccm Investment Advisers LLC Merck & Co., Inc. Transaction History

Ccm Investment Advisers LLC

$887 Million
Q3 2024

A detailed history of Ccm Investment Advisers LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ccm Investment Advisers LLC holds 124,734 shares of MRK stock, worth $12.3 Million. This represents 1.6% of its overall portfolio holdings.

Number of Shares

124,734

Previous 126,575 1.45%

Holding current value

$12.3 Million

Previous $15.7 Million 9.6%

% of portfolio

1.6%

Previous 1.85%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$111.15 - $128.97 $204,627 - $237,433	-1,841 Reduced 1.45%	124,734 $14.2 Million
Q2 2024 Jul 11, 2024	SELL	$123.8 - $132.96 $55,957 - $60,097	-452 Reduced 0.36%	126,575 $15.7 Million
Q1 2024 May 17, 2024	SELL	$113.24 - $131.95 $1.01 Million - $1.18 Million	-8,905 Reduced 6.55%	127,027 $16.8 Million
Q4 2023 Mar 05, 2024	BUY	$100.18 - $109.02 $223,902 - $243,659	2,235 Added 1.67%	135,932 $14.8 Million
Q3 2023 Dec 08, 2023	BUY	$102.95 - $114.33 $49,004 - $54,421	476 Added 0.36%	133,697 $13.8 Million
Q2 2023 Aug 21, 2023	SELL	$108.61 - $118.38 $15,857 - $17,283	-146 Reduced 0.11%	133,221 $15.4 Million
Q1 2023 May 17, 2023	BUY	$102.94 - $114.86 $524,479 - $585,211	5,095 Added 3.97%	133,367 $14.2 Million
Q4 2022 Feb 15, 2023	SELL	$87.44 - $112.11 $1.35 Million - $1.73 Million	-15,464 Reduced 10.76%	128,272 $14.2 Million
Q3 2022 Nov 09, 2022	SELL	$84.53 - $94.96 $180,978 - $203,309	-2,141 Reduced 1.47%	143,736 $12.4 Million
Q2 2022 Jul 27, 2022	SELL	$83.49 - $94.64 $108,954 - $123,505	-1,305 Reduced 0.89%	145,877 $13.3 Million
Q1 2022 May 03, 2022	SELL	$73.51 - $82.4 $857,714 - $961,443	-11,668 Reduced 7.35%	147,182 $12.1 Million
Q4 2021 Feb 01, 2022	BUY	$72.28 - $90.54 $1,879 - $2,354	26 Added 0.02%	158,850 $12.2 Million
Q3 2021 Oct 26, 2021	BUY	$71.68 - $78.83 $507,781 - $558,431	7,084 Added 4.67%	158,824 $11.9 Million
Q2 2021 Jul 30, 2021	BUY	$70.31 - $77.77 $704,928 - $779,722	10,026 Added 7.07%	151,740 $11.8 Million
Q1 2021 May 07, 2021	BUY	$68.86 - $81.11 $304,154 - $358,262	4,417 Added 3.22%	141,714 $10.9 Million
Q4 2020 Feb 25, 2021	BUY	$71.77 - $79.65 $56,267 - $62,445	784 Added 0.57%	137,297 $11.2 Million
Q3 2020 Nov 10, 2020	SELL	$73.18 - $82.95 $159,678 - $180,996	-2,182 Reduced 1.57%	136,513 $11.3 Million
Q2 2020 Aug 10, 2020	BUY	$70.42 - $80.13 $24,717 - $28,125	351 Added 0.25%	138,695 $10.7 Million
Q1 2020 May 22, 2020	SELL	$63.36 - $87.82 $724,775 - $1 Million	-11,439 Reduced 7.64%	138,344 $10.6 Million
Q4 2019 Feb 20, 2020	SELL	$77.58 - $87.54 $193,019 - $217,799	-2,488 Reduced 1.63%	149,783 $13.6 Million
Q3 2019 Nov 19, 2019	SELL	$76.08 - $82.93 $493,378 - $537,801	-6,485 Reduced 4.08%	152,271 $12.8 Million
Q2 2019 Aug 05, 2019	SELL	$69.84 - $81.59 $675,352 - $788,975	-9,670 Reduced 5.74%	158,756 $13.3 Million
Q1 2019 May 02, 2019	BUY	$69.58 - $79.36 $23,100 - $26,347	332 Added 0.2%	168,426 $14 Million
Q4 2018 Feb 12, 2019	BUY	$65.24 - $75.71 $1.48 Million - $1.72 Million	22,672 Added 15.59%	168,094 $12.8 Million
Q3 2018 Nov 05, 2018	BUY	$57.69 - $67.84 $2.89 Million - $3.39 Million	50,039 Added 52.46%	145,422 $10.3 Million
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $4.27 Million - $5.01 Million	83,923 Added 732.31%	95,383 $5.79 Million
Q1 2018 May 09, 2018	SELL	$50.96 - $59.23 $135,400 - $157,374	-2,657 Reduced 18.82%	11,460 $624,000
Q4 2017 Feb 22, 2018	SELL	$51.62 - $61.64 $80,940 - $96,651	-1,568 Reduced 10.0%	14,117 $794,000
Q3 2017 Nov 02, 2017	BUY	$58.67 - $63.13 $920,238 - $990,194	15,685	15,685 $1 Million

Others Institutions Holding MRK

# of Institutions

3,803

Shares Held

1.9B

Call Options Held

13.5M

Put Options Held

11.1M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $250B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ccm Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ccm Investment Advisers LLC with notifications on news.

Account

Ccm Investment Advisers LLC Merck & Co., Inc. Transaction History